Cited by 38Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

The GPR17 receptor-A promising goal for therapy and a potential marker of the neurodegenerative process in multiple sclerosis

Open access
Dziedzic, Angela, Miller, Elzbieta, Saluk-Bijak, Joanna, Bijak, Michal·2020·International Journal of Molecular Sciences

Abstract

One of the most important goals in the treatment of demyelinating diseases such as multiple sclerosis (MS) is, in addition to immunomodulation, reconstruction of the lost myelin sheath. The modulator of the central nervous system myelination is the metabotropic receptor coupled to the G-protein: GPR17. GPR17 receptors are considered to be sensors of local damage to the myelin sheath, and play a role in the reconstruction and repair of demyelinating plaques caused by ongoing inflammatory processes. GPR17 receptors are present on nerve cells and precursor oligodendrocyte cells. Under physiological conditions, they are responsible for the differentiation and subsequent maturation of oligodendrocytes, while under pathological conditions (during damage to nerve cells), their expression increases to become mediators in the demyelinating processes. Moreover, they are essential not only in both the processes of inducing damage and the death of neurons, but also in the local repair of the damaged myelin sheath. Therefore, GPR17 receptors may be recognized as the potential goal in creating innovative therapies for the treatment of the neurodegenerative process in MS, based on the acceleration of the remyelination processes. This review examines the role of GRP17 in pathomechanisms of MS development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21051852

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The strong activation of immune- and inflammation-related genes, as well as differential expression of remyelination regulators like Gpr17, suggest that the homeostasis of white matter is compromised at old age.

    “The strong activation of immune- and inflammation-related genes, as well as differential expression of remyelination regulators like Gpr17 (Dziedzic et al., 2020; Rivera et al., 2021), suggest that the homeostasis of this region is compromised at old age.”

    From Atlas of the aging mouse brain reveals white matter as vulnerable foci (2023) · cites this paper as Dziedzic et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 120 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Dziedzic, A., Miller, E., Saluk-Bijak, J., & Bijak, M.
Affiliations
  • University of Łódź (PL)
  • Department of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 93-113 Lodz, Poland
  • Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland
  • Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-03-08
Volume
21
Issue
5
Pages
1852
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3010042062
Cited by
38
References
120
Citations by year
2026: 6 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 2
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Lodz (506/1136)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
GPR17, multiple sclerosis, demyelination, remyelination, oligodendrocyte differentiation, G protein-coupled receptors, neurodegeneration, demyelinating plaques, neuroinflammation, therapeutic target
MeSH terms
Remyelination, Animals, Humans, Multiple Sclerosis, Biomarkers, Neurodegenerative Diseases, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review